Episode

Optimizing HSCT in Blood Cancers

Podcast: Treating Blood Cancers
Published: Jun 2, 2026
Duration seconds: 2320
Processing state: not_requested
Canonical source: https://treatingbloodcancers.org/e120/?utm_source=rss&utm_medium=rss&utm_campaign=e120
Audio: https://media.blubrry.com/treating_blood_cancers/content.blubrry.com/treating_blood_cancers/TBC_E120-Dr_Muffly-HSCT_mixdown_Production.mp3
JSON: /v1/public/podcasts/treating-blood-cancers-14318/episodes/optimizing-hsct-in-blood-cancers
Markdown: /podcast/treating-blood-cancers-14318/optimizing-hsct-in-blood-cancers.md

Actions

POST https://stenobird.com/v1/public/podcasts/treating-blood-cancers-14318/episodes/optimizing-hsct-in-blood-cancers/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/treating-blood-cancers-14318/optimizing-hsct-in-blood-cancers.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Lori Muffly MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients